Skip to main content

PCR Amplification on Whole Blood Samples Treated with Different Commonly Used Anticoagulants.

Djordjevic V, Stankovic M, Nikolic A, Antonijevic N, Rakicevic L J, Divac A, Radojkovic M

Publication: Pediatr Hematol Oncol (2006) • Vol 23 • Page 517PMID: 16849283View on PubMed

Purpose

To assess the impact of commonly used anticoagulants on PCR amplification of whole blood and extracted DNA, and to optimize PCR-based screening using whole blood as a template.

Conclusion

PCR amplification of whole blood (1 uL to a 1:10 dilution) treated with anticoagulants (lithium heparin, sodium citrate, K3EDTA) was comparable to extracted DNA. PCR amplification of blood treated with sodium heparin alone failed to generate a product.

Studies (3)

Purpose

To determine if treatment of whole blood with anticoagulants affects PCR amplification of extracted DNA.

Summary of Findings

PCR amplification of DNA extracted from blood samples were comparable across samples treated with anticoagulants.

  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
  • Platforms

    DNAPCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Lithium heparin
    Potassium EDTA
    Sodium citrate
    Sodium heparin